Condition
Resectable Pancreatic Ductal Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Resectable Pancreatic Ductal Adenocarcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Canada (1)). By phase: Phase 2 (2), Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Resectable Pancreatic Ductal Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SMAD4-tailored neoadjuvant therapy for pancreatic cancer that can be surgically removed | Phase 2 | Chicago, Illinois | Recruiting | Aug 6, 2026 |
| Samuraciclib given before surgery or chemotherapy for certain pancreatic cancers | Phase 1 | Seattle, Washington | Recruiting | Jun 12, 2026 |
| Exploring how diet and gut bacteria affect chemotherapy response in pancreatic cancer | — | Atlanta, Georgia | Recruiting | Sep 19, 2024 |
| Tumor DNA and protein testing to understand pancreatic cancer treatment response | — | Vancouver, British Columbia | Recruiting | Aug 28, 2024 |
| Imaging cancer-associated fibroblasts in localized pancreatic cancer | Phase 2 | Rochester, Minnesota | Recruiting | Aug 29, 2022 |
| Targeted therapy for pancreatic cancer using new drugs | Early Phase 1 | Portland, Oregon | Recruiting | Jul 2, 2019 |
All recruiting trials (6)
-
SMAD4-tailored neoadjuvant therapy for pancreatic cancer that can be surgically removed
This trial tests whether using SMAD4 mutation status can guide pre-surgery chemotherapy for patients with resectable or borderline resectable pancreatic ductal adenocarcinoma.
-
Samuraciclib given before surgery or chemotherapy for certain pancreatic cancers
This study tests whether taking samuraciclib before standard treatment is safe and helps patients with localized pancreatic cancer.
-
Exploring how diet and gut bacteria affect chemotherapy response in pancreatic cancer
This study is testing how diet and gut bacteria affect how well people with pancreatic cancer respond to chemotherapy.
-
Tumor DNA and protein testing to understand pancreatic cancer treatment response
This trial will test whether measuring tumor DNA and proteins from people with resectable or locally advanced pancreatic ductal adenocarcinoma can be done quickly enough and provide information about how their cancer responds to standard chemotherapy.
-
Imaging cancer-associated fibroblasts in localized pancreatic cancer
This study is testing a special type of scan to see if it can help find certain cells in patients with localized pancreatic cancer and predict how well they will do after surgery.
-
Targeted therapy for pancreatic cancer using new drugs
This study is testing new targeted therapies for pancreatic cancer to see how well they work and if they are safe for patients at different stages of the disease.
Related topics
Quick answers
How many Resectable Pancreatic Ductal Adenocarcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.